International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma (Q66388440)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
clinical trial

    Statements

    short name
    LBL 2018 (English)
    0 references
    title
    LBL 2018 - International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma (English)
    0 references
    country
    Austria
    0 references
    Belgium
    0 references
    Denmark
    0 references
    Finland
    0 references
    France
    0 references
    Germany
    0 references
    Hungary
    0 references
    Ireland
    0 references
    Israel
    0 references
    Italy
    0 references
    Netherlands
    0 references
    Norway
    0 references
    Poland
    0 references
    Portugal
    0 references
    Slovakia
    0 references
    Spain
    0 references
    Sweden
    0 references
    Switzerland
    0 references
    start time
    1 August 2019
    0 references
    end time
    31 October 2027
    0 references
    number of participants
    683
    0 references
    research intervention
    (RS)-cyclophosphamide
    0 references
    prednisone
    0 references
    prednisolone
    0 references
    doxorubicin
    0 references
    cytarabine
    0 references
    ifosfamide
    0 references
    asparaginase
    0 references
    mercaptopurine
    0 references
    6-thioguanine
    0 references
    pegaspargase
    0 references
    vindesine
    0 references
    maximum age
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q66388440&oldid=2136625727"